T2 Biosystems Inc (NASDAQ:TTOO) Shorts Increased By 1.6%

June 27, 2018 - By Sarah Harris

T2 Biosystems, Inc. (NASDAQ:TTOO) Corporate Logo

It was recorded an increase on T2 Biosystems Inc (NASDAQ:TTOO)’s short interest with 1.6%. In June was published TTOO’s total 1.65 million short interest by FINRA. The up change of 1.6% from 1.62M shares was reported. T2 Biosystems Inc (NASDAQ:TTOO) has 134,900 shares average volume. It’ll cost 12 days for TTOO to recover its previous position. 8.24% is T2 Biosystems Inc float short.

TTOO hit $8.12 during the last trading session after $0.04 change.T2 Biosystems, Inc. has volume of 659,173 shares. Since June 27, 2017 TTOO has risen 181.59% and is uptrending. TTOO outperformed the S&P500 by 169.02%.

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States.The firm is valued at $342.01 million. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine.Currently it has negative earnings. The firm also offers T2Dx, a bench-top instrument for sepsis, Lyme disease, and other applications, as well as T2Candida panel for the detection of candida species in human whole blood specimens.

T2 Biosystems, Inc. (NASDAQ:TTOO) Ratings Coverage

In total 5 analysts cover T2 Biosystems (NASDAQ:TTOO). “Buy” rating has 4, “Sell” are 0, while 1 are “Hold”. 80% are bullish. With $1400 highest and $5.2 lowest PT T2 Biosystems has $9.55 average PT or 17.61% above the current ($8.12) price. 10 are the (NASDAQ:TTOO)’s analyst reports since January 25, 2018 according to StockzIntelligence Inc. On Monday, February 12 the firm earned “Buy” rating by H.C. Wainwright. On Thursday, March 29 the stock of T2 Biosystems, Inc. (NASDAQ:TTOO) earned “Buy” rating by H.C. Wainwright. The company rating was upgraded by Leerink Swann on Friday, June 1. On Thursday, January 25 H.C. Wainwright maintained T2 Biosystems, Inc. (NASDAQ:TTOO) with “Buy” rating. On Wednesday, May 30 the rating was maintained by H.C. Wainwright with “Buy”. On Wednesday, May 9 Janney Capital upgraded the shares of TTOO in report to “Buy” rating. On Wednesday, May 9 the stock of T2 Biosystems, Inc. (NASDAQ:TTOO) earned “Buy” rating by H.C. Wainwright. On Wednesday, March 7 the stock of T2 Biosystems, Inc. (NASDAQ:TTOO) earned “Buy” rating by H.C. Wainwright. On Wednesday, March 7 Canaccord Genuity maintained T2 Biosystems, Inc. (NASDAQ:TTOO) with “Buy” rating.

For more T2 Biosystems, Inc. (NASDAQ:TTOO) news brought out briefly go to: Seekingalpha.com, Globenewswire.com, Globenewswire.com, Seekingalpha.com or Seekingalpha.com. The titles are as follows: “T2 Biosytems: The Story Is Just Beginning” brought out on June 03, 2018, “T2 Biosystems Reports Granting of Inducement Awards” on June 06, 2018, “T2 Biosystems Added to the Russell 3000® Index” with a publish date: June 25, 2018, “T2 Biosystems By The Numbers” and the last “T2 Biosystems: Still A Buy After The Rally” with publication date: June 15, 2018.

T2 Biosystems, Inc. (NASDAQ:TTOO) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.